Merrimack Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
MACK Nasdaq 8731 http://www.merrimackpharma.com 6.20 +0.00

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Merrimack Pharmaceuticals Inc

ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : September 29, 2016 - Sep 29th, 2016 1:44 pm
4:11 pm Merrimack Pharma will present the final results of the Phase 3 NAPOLI-1 study in a poster at the ESMO Congress - Sep 28th, 2016 8:11 pm
Merrimack to Present Final Results of Phase 3 NAPOLI-1 Study at the European Society for Medical Oncology 2016 Congress - Sep 28th, 2016 8:09 pm
Bullish and Bearish Reversals for the Week - Sep 26th, 2016 4:55 pm
Cash Dwindles as Merrimack Fights Cancer (MACK) - Sep 13th, 2016 8:38 pm
ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : September 12, 2016 - Sep 12th, 2016 3:17 pm
Why Merrimack Pharmaceuticals Inc Fell 20.3% in August - Sep 12th, 2016 11:54 am
Ericsson, Merrimack Drop Into Tuesday’s 52-Week Low Club - Sep 6th, 2016 8:04 pm
ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : September 2, 2016 - Sep 2nd, 2016 2:11 pm
Noble Corp., Express Stay in 52-Week Low Club Again Friday - Aug 26th, 2016 8:04 pm
Express, Noble Corp. Lead Thursday’s 52-Week Low Club - Aug 25th, 2016 8:04 pm
7 Stocks Under $10 Making Big Up Moves - Aug 24th, 2016 11:08 am
ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : August 22, 2016 - Aug 22nd, 2016 3:41 pm
MERRIMACK PHARMACEUTICALS INC Financials - Aug 12th, 2016 5:04 pm
Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 - Aug 10th, 2016 4:01 pm
ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : August 9, 2016 - Aug 9th, 2016 5:49 pm
Merrimack Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MACK-US : August 8, 2016 - Aug 8th, 2016 12:28 pm
Edited Transcript of MACK earnings conference call or presentation 4-Aug-16 8:30pm GMT - Aug 5th, 2016 8:08 pm
Merrimack (MACK) Q2 Loss Wider than Expected, Sales Top - Aug 5th, 2016 8:02 pm
Merrimack reports 2Q loss - Aug 4th, 2016 10:17 pm